These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [New drugs and European procedures of approval. The European Agency for the Evaluation of Medicinal Products' role]. Ainsworth MA. Ugeskr Laeger; 2003 Apr 14; 165(16):1648-9. PubMed ID: 12756819 [Abstract] [Full Text] [Related]
6. The regulatory system in europe with special emphasis on allergen products. Lorenz AR, Luttkopf D, Seitz R, Vieths S. Int Arch Allergy Immunol; 2008 Apr 14; 147(4):263-75. PubMed ID: 18648190 [Abstract] [Full Text] [Related]
7. [European drug policy]. Sauer F. Bull Mem Acad R Med Belg; 1993 Apr 14; 148(5-6):207-12; discussion 212-6. PubMed ID: 8142930 [Abstract] [Full Text] [Related]
8. [Registration of new medicinal products in Europe]. Singer E. Onkologie; 2008 Apr 14; 31 Suppl 2():64-6. PubMed ID: 18487872 [Abstract] [Full Text] [Related]
9. [Scientific advice by the nationally competent authority and by the EMEA on the conduct of clinical trials]. Dejas-Eckertz P, Schäffner G. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Apr 14; 48(4):423-8. PubMed ID: 15830253 [Abstract] [Full Text] [Related]
10. [Drugs in Europe]. Bouzy C, Abadie E. Rev Prat; 2002 Mar 01; 52(5):510-4. PubMed ID: 11949504 [Abstract] [Full Text] [Related]
11. Medicines for children licensed by the European Agency for the Evaluation of Medicinal Products. Ceci A, Felisi M, Catapano M, Baiardi P, Cipollina L, Ravera S, Bagnulo S, Reggio S, Rondini G. Eur J Clin Pharmacol; 2002 Nov 01; 58(8):495-500. PubMed ID: 12451425 [Abstract] [Full Text] [Related]
12. [Safety monitoring of cell-based medicinal products (CBMPs)]. Funk MB, Frech M, Spranger R, Keller-Stanislawski B. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Nov 01; 58(11-12):1239-46. PubMed ID: 26391098 [Abstract] [Full Text] [Related]
13. [Approval of drugs by national and European agencies--from the viewpoint of drug approval committee A]. Henschler D. Z Arztl Fortbild Qualitatssich; 1997 Nov 01; 91(7):600-3. PubMed ID: 9527449 [Abstract] [Full Text] [Related]
14. [Review of the development in European Legislation on the harmonisation of the laws for medicinal products]. Lehmann B. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Jul 01; 51(7):713-21. PubMed ID: 18584107 [Abstract] [Full Text] [Related]
15. Marketing authorization of veterinary medicinal products in Poland. Sztabińska-Koncka H, Lewicki J. Regul Toxicol Pharmacol; 1997 Aug 01; 26(1 Pt 1):129-33. PubMed ID: 9339489 [Abstract] [Full Text] [Related]
16. Legal requirements for the quality of herbal substances and herbal preparations for the manufacturing of herbal medicinal products in the European union. Vlietinck A, Pieters L, Apers S. Planta Med; 2009 Jun 01; 75(7):683-8. PubMed ID: 19204891 [Abstract] [Full Text] [Related]
20. EMEA (European Medicines Evaluation Agency) and the new pharmaceutical procedures for Europe. Jones K, Jefferys D. Health Trends; 1994 Nov 01; 26(1):10-3. PubMed ID: 10171959 [Abstract] [Full Text] [Related] Page: [Next] [New Search]